320 likes | 358 Views
Cardiac Failure. Richard Price Consultant, Intensive Care, RAH. Objectives. Overview of terminology Pathophysiology of cardiac failure Clinical features, x-rays and echos Outline of acute and chronic treatments. Cardiac failure.
E N D
Cardiac Failure • Richard Price • Consultant, Intensive Care, RAH.
Objectives • Overview of terminology • Pathophysiology of cardiac failure • Clinical features, x-rays and echos • Outline of acute and chronic treatments
Cardiac failure • A clinical syndrome with signs and symptoms of congestion and circulatory failure
Epidemiology • Prevalence 10% in >65 years • 2% of general medical admissions • In US is the most common cause of hospitalisation in > 65 years • Mortality 60% at 5 yrs post diagnosis • Is as ‘malignant’ as the most common causes of cancer
Terminology • Acute heart failure • Chronic Heart Failure • Decompensated CHF • (Right heart failure and high output failure)
Terminology • LV dysfunction • Systolic dysfunction • (abnormal contraction) • Diastolic dysfunction • (abnormal relaxation)
Aetiology • Coronary artery disease • Hypertension • Valvular heart disease • Cardiomyopathies eg viral, alcoholic, septic
Performance Sympathetics Normal Failing Preload
Performance Higher pressure needed for the same performance P1 P2 Preload
Performance Sympathetics Normal Failing Afterload
Performance Less able to cope with afterload Afterload
CO R-A-A SNS Na+ Vasoconstriction Afterload Preload
Oedema • Downstream pressure • Colloid osmotic pressure • Lymphatic drainage • Capillary Leak
Clinical presentation • Short of breath • Hypoxaemia • Tachycardia • Bilateral lung crepitations • Peripheral Oedema - takes time • Hypotension, ⇓ peripheral perfusion
Investigations • ECG • CXR • Basic bloods • Echocardiography
Fluid in the fissure Perihilar congestion Large Heart
Management • Acute • O2 • IV opiates • IV diuretics • IV nitrates • CPAP • Cardiogenic shock • Inotropes • Balloon pumping • Ventilation
CPAP • First described in: Lancet 1936; II: 981 • Meta-analysis: Lancet 2006; 357: 1155 • 3CPO study - NEJM 2008; 359: 142 • no mortality difference at 7 days vs standard care • Hypoxic despite medical therapy - CPAP • NIV - probably no benefit over CPAP
ECG Monitoring CVP Line Peribronchiolar cuffing
Chronic Management • Diuretics • ACE Inhibitors • β-blockers • Spironolactone • Digoxin
Chronic Management • Diuretics • ACE Inhibitors • β-blockers • Spironolactone • Digoxin Reduce symptoms Decrease mortality, improve ejection fraction, improve symptoms Decrease mortality with severe disease May reduce hospitalisation
Cardiac resynchronisation Defibrillators (ICD) Assist Devices (LVAD)
Summary A clinical syndrome due to variable pathology Physiological response leads to further deterioration Investigations aimed at diagnosis and aetiology Treatment aims to reverse the cause and reduce preload and afterload Common, serious and often progressive
Further reading • McMurray JJV. Systolic heart failure. New England Journal of Medicine 2010; 362: 228.